EPO and myelodysplastic syndrome: Bone marrow progenitors from patients with MDS display diminished STAT5 activation and transcriptional response to erythropoietin (Epo) stimulation compared to age matched controls despite normal Epo receptor (EpoR) membrane density [1], [2].